C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
11/2004
11/30/2004	US6825043 Fluorous tagging compounds and methods of increasing the fluorous nature of compounds
11/30/2004	CA2362117C A system for cell-based screening
11/30/2004	CA2264088C Color-safe bleach boosters, compositions and laundry methods employing same
11/30/2004	CA2251795C Novel n-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
11/25/2004	WO2004101528A2 Isoquinoline derivatives and their use as gfat inhibitors
11/25/2004	WO2004101506A1 Glyoxalase inhibitors
11/25/2004	WO2004100950A1 ‘(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)-propyl!phenyl derivatives as beta2 agonists
11/25/2004	WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040235891 1-(2,2-diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline- 2-carbaldehyde; for treating sleep disorders
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235750 Thiocarbamate inhibitors of alpha-4 integrins
11/25/2004	US20040234622 Sulfonamide derivatives
11/25/2004	CA2525438A1 Glyoxalase inhibitors
11/25/2004	CA2525006A1 `(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)-propyl!phenyl derivatives as beta2 agonists
11/25/2004	CA2524958A1 Isoquinoline derivatives and their use as gfat inhibitors
11/24/2004	EP1478626A2 Guanidino compounds
11/24/2004	EP1478363A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
11/24/2004	EP1478361A2 Arylsulfone derivatives
11/24/2004	EP0976732B1 1,4-substituted cyclic amine derivatives
11/24/2004	CN1549716A 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents
11/24/2004	CN1548423A Application of bisbenzylisoquinoline-(7-0-11')-single ether bond alkaloid derivative and analog in treating fibrosis related diseases
11/18/2004	WO2004099150A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	WO2004099129A2 Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
11/18/2004	US20040230055 Using alkylmetal reagents for directed metalation of azaaromatics
11/18/2004	US20040229955 Antibacterial agents
11/18/2004	US20040229910 Therapeutic compounds
11/18/2004	US20040229904 Compounds useful for the treatment of diseases
11/18/2004	US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004	US20040229858 VLA-4 inhibitor compounds
11/18/2004	US20040229846 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
11/18/2004	US20040229819 Hemiasterlin derivatives and uses thereof
11/18/2004	CA2524927A1 Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
11/18/2004	CA2523235A1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/17/2004	EP1477482A1 Novel phenylalanine derivative
11/17/2004	EP1477186A1 Antipruritics
11/17/2004	EP1477167A1 [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists
11/17/2004	CN1547575A Novel phenylalkyl diamine and amide analogs
11/16/2004	US6818774 2-(s)-(6-(4-fluoro-benzyloxy)-3-oxo-3,4-dihydro-1h-isoquinolin -2-yl)- propionamide for example; alzheimer's disease or senile dementia
11/16/2004	US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease
11/16/2004	CA2107008C Antiarrhythmic and cardioprotective substituted -1(2h)isoquinolines, process for their production, medicament containing them and their use for the production of a medicament for combating heart failures
11/11/2004	WO2004096774A1 Acyl isoindoline derivatives and acyl isoquinoline derivatives as anti-viral agents
11/11/2004	WO2004085403B1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
11/11/2004	WO2004067675A3 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
11/11/2004	WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
11/11/2004	US20040224978 CCR8 inhibitors
11/10/2004	EP1474399A1 Benzenesulfonamide derivatives as antipsychotic agents
11/10/2004	EP1159258B1 Amide compounds for the potentiation of cholinergic activity
11/10/2004	CN1545700A Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
11/09/2004	US6815440 For therapy and prophylaxis of disorders in the course of which is involved an increased activity of matrix-degrading metalloproteinases
11/04/2004	WO2004094386A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)
11/04/2004	WO2004080423A3 7-amino- isoindolyl compounds amd their pharmaceutical uses
11/04/2004	WO2004067498A3 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/04/2004	WO2003103662A3 Inhibitors of glycoprotein vi
11/04/2004	US20040220235 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/04/2004	US20040220222 Malonamide derivatives
11/04/2004	US20040220215 antidiabetic agents; insulin resistance; adjust glucose tolerance; anticholesterol agents; cardiovascular disorders; obesity; antiinflammatory agents
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	CA2518180A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)
11/03/2004	EP1472215A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
11/03/2004	EP1305278B1 Ruthenium complexes and their use in asymmetric hydrogenation
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004	CN1173953C Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
10/2004
10/28/2004	WO2004092164A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
10/28/2004	WO2004092125A2 Using alkylmetal reagents for directed metalation of azaaromatics
10/28/2004	WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004	CA2522084A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
10/28/2004	CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	CA2521383A1 Using alkylmetal reagents for directed metalation of azaaromatics
10/27/2004	EP1470119A1 Benzothiophene compounds having antiinfective activity
10/27/2004	EP1469851A1 Melanocortin receptor agonists
10/27/2004	EP0960108B1 Matrix metalloproteinase inhibitors
10/27/2004	EP0929527B1 Pictet-spengler reaction for the synthesis of tetrahydroisoquinolines and related heterocyclic compounds
10/27/2004	CN1539834A Method for preparing handy amino-tetrahydrofurans or its salts
10/27/2004	CN1539833A Funcitonal molecule material containing four tertiary amine branches and preparation method
10/27/2004	CN1539832A Process for preparing oxazolines from tetrahydrofurans
10/27/2004	CN1539823A Method for preparing new demethyl conclaurine and medinal salt
10/27/2004	CN1539816A IL-8 receptor antagonist
10/26/2004	US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
10/21/2004	WO2004009556A9 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
10/21/2004	US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents
10/21/2004	US20040209912 Substituted isoquinoline derivatives and their use as anticonvulsants
10/21/2004	US20040209884 Fused azabicycic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor
10/20/2004	EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
10/20/2004	CN1538848A Novel Benzo-fused heterocycles
10/20/2004	CN1537846A Intermediates for making HIV-protease inhibitors and method for making HIV-protease inhibitors
10/19/2004	US6806369 N-formyl-n-hydroxy-2-(5-isoquinolinoxy)ethylamine anti-bacterial compounds
10/19/2004	US6806365 N-alkanoylphenylalamine derivatives
10/14/2004	WO2004087671A1 Preparation of quinapril hydrochloride
10/14/2004	WO2003104282A3 Glycoprotein vi - fc fusion protein for treating vascular disorders
10/14/2004	US20040204591 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group
10/14/2004	US20040204449 New isoquinoline compounds
10/14/2004	US20040204447 Isoquinolinone derivatives and their use as therapeutic agents
10/14/2004	US20040204446 Nitrogen compounds such as N-(2-Fluoro-benzyl)-N-indan-2-yl-2-(3-methyl-2-o-tolyl-piperidin-1-yl) -acetamide, administered for prophylaxis arthritis, psoriasis, cardiovascular disorders, reperfusion injury or respiratory system disorders
10/14/2004	US20040204421 Certain 1,3-disubstituted isoquinoline derivatives
10/14/2004	US20040204412 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer
10/14/2004	US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders
10/14/2004	US20040204257 System for and a method of manufacturing personal golf putters

1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 119